Sinovac Biotech Ltd. (Nasdaq:SVA) a leading provider of biopharmaceutical products in China, announced that Mr. Jacob Ho, Acting Chief Financial Officer, Ms. Helen Yang, Investor Relations Manager, and Ms. Chris Lee, Investor Relations, are scheduled to present at the Rodman & Renshaw Annual China Investment Conference. The conference will be held in Shanghai from March 6th to 8th. The Sinovac team will present at 11:30 am China Standard Time on March 7th and will participate in one-on-one meetings that day.
Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against the hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China.
Orofino Gold Corp. (PINK OTC: ORFG.PK) is a Colombian based gold producer, founded as a private company in 2009 by former executives with over 50 cumulative years in mining exploration, finance, and development expertise. Orofino’s corporate objective is to continue to build shareholder value through the exploration and development of The Senderos de Oro Gold Camp and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.
ORFG has announced an expanding involvement of renown academic Dr. Hans J. Bocker as Orofino continues to increase its activities in preparation for major development on its Colombian mining concessions.
Read more at: http://crwewallstreet.com/?p=16582